key: cord-0806343-wxl07lrj authors: Kerber, Alyssa A.; Soma, David B.; Youssef, Molly J. title: Chilblains‐like dermatologic manifestation of COVID‐19 diagnosed by serology via multidisciplinary virtual care date: 2020-06-04 journal: Int J Dermatol DOI: 10.1111/ijd.14974 sha: caf31c835ae2636c05e6a75d2593e0fcfe1cf128 doc_id: 806343 cord_uid: wxl07lrj nan (COVID-19) have been described but with limited knowledge of timeline and often absence of coronavirus PCR and/or serologic testing. With the current COVID-19 pandemic, there has been increased utilization of telehealth visits, which can allow for rapid multispecialty evaluation in a safe environment. We demonstrate optimized use of telehealth visits and share a unique delayed cutaneous manifestation of COVID-19, confirmed by serologic testing. A 7-year-old male was evaluated twice for concerns regarding the feet. These visits were performed as video telehealth encounters in the general pediatric outpatient clinic. The first telehealth visit was for right toe pain, swelling, and inability to bear weight in the setting of an injury sustained while kicking the bottom wooden section of a couch. Quality photos were sent via the online medical record system and revealed erythema and mild edema of the right dorsal toes and localized violaceous vesicular changes in the right plantar foot (Fig. 1a,b) . Radiograph performed revealed no osseous abnormality. The patient was diagnosed with soft tissue changes related to trauma. The second telehealth visit was performed because of ongoing skin changes, now involving both feet. The patient reported minimal pain and mild pruritus. The lesions visualized on video were increasingly violaceous and involved the plantar feet in addition to toes. Subsequent photos revealed chilblains-like changes in the feet (Fig. 2a,b) . There were violaceous lesions and erosions on the dorsal toes. Owing to concerns for skin manifestation of COVID-19 or other systemic disease, a Pediatric Dermatology electronic consultation was performed. Pediatric Dermatology recommended additional blood work and agreed with testing for COVID-19. Complete blood count, ESR, and comprehensive metabolic profile were unremarkable. EBV antibody profile was negative. Nasopharyngeal swab for SARS-CoV-2 PCR was negative. Serum SARS-CoV-2 IgG antibodies were positive. Of note, the patient denied fever or respiratory symptoms. The most recent infectious symptoms occurred approximately 2 months prior when the patient was seen in the emergency department for fever, pharyngitis, and cough. Streptococcal testing and influenza testing were performed and found negative. COVID-19 has become a pandemic condition, and dermatologic manifestations are being increasingly described. There have been reports of transient livedo reticularis, urticarial-like, vesicular, and dengue fever-like eruptions, which tend to occur during infection. [1] [2] [3] [4] Recently, reddish-purple lesions on the distal fingers and toes, similar in appearance to perniosis (chilblains), have been described in patients with documented or suspected COVID-19. 5, 6 It has been hypothesized that these lesions could be a late manifestation of COVID-19, supported by the fact that some of the patients reported symptoms or contact with higherrisk individuals weeks prior to the appearance of these skin lesions but lacked serologic testing. 6, 7 Indeed in our patient, there was a history of a febrile illness approximately 6 weeks Cutaneous manifestations in COVID-19: a first perspective A Dermatologic manifestation of COVID-19: transient livedo reticularis Varicella-like exanthem as a specific COVID-19-associated skin manifestation: multicenter case series of 22 patients COVID-19 can present with a rash and be mistaken for dengue A case of COVID-19 presenting in clinical picture resembling chilblains disease. First report from the Middle East Chilblain-like lesions on feet and hands during the COVID-19 pandemic Acral cutaneous lesions in the time of COVID-19 Funding source: None. doi: 10.1111/ijd.14974